Skip to Main Content

Author Details

Bing Zhang
Baylor College of Medicine
2005
144
48
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36114956Single-cell transcriptomic analysis reveals the adverse effects of cadmium on the trajectory of neuronal maturation.Cell Biol Toxicol2023
36114956Single-cell transcriptomic analysis reveals the adverse effects of cadmium on the trajectory of neuronal maturation.Cell Biol Toxicol2023
37575948Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma.Natl Sci Rev2023
37619559A proteogenomics data-driven knowledge base of human cancer.Cell Syst2023
36711982Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identification.bioRxiv2023
37137501The Breast Cancer Proteome and Precision Oncology.Cold Spring Harb Perspect Med2023
37072382PepQuery2 democratizes public MS proteomics data for rapid peptide searching.Nat Commun2023
37172086Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.Sci Adv2023
37104137Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials.Tomography2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
37501682Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.Cancer Res Commun2023
37494474Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.Sci Transl Med2023
37619559A proteogenomics data-driven knowledge base of human cancer.Cell Syst2023
37575948Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma.Natl Sci Rev2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
37501682Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.Cancer Res Commun2023
37494474Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.Sci Transl Med2023
37172086Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.Sci Adv2023
37104137Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials.Tomography2023
37072382PepQuery2 democratizes public MS proteomics data for rapid peptide searching.Nat Commun2023
37137501The Breast Cancer Proteome and Precision Oncology.Cold Spring Harb Perspect Med2023
36711982Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identification.bioRxiv2023
34114372A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.Cancer Rep (Hoboken)2022
36001024Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.Cancer Discov2022
36271853OmicsEV: a tool for comprehensive quality evaluation of omics data tables.Bioinformatics2022
35863823Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.J Immunother Cancer2022
36266629Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.Clin Proteomics2022
35406663Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.Cells2022
36258226Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness.Breast Cancer Res2022
34114372A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.Cancer Rep (Hoboken)2022
35236940Cancer proteogenomics: current impact and future prospects.Nat Rev Cancer2022
35121782NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.Sci Rep2022
35406663Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.Cells2022
36001024Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.Cancer Discov2022
36271853OmicsEV: a tool for comprehensive quality evaluation of omics data tables.Bioinformatics2022
35863823Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.J Immunother Cancer2022
36266629Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.Clin Proteomics2022
36258226Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness.Breast Cancer Res2022
35121782NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.Sci Rep2022
35236940Cancer proteogenomics: current impact and future prospects.Nat Rev Cancer2022
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
34110646A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.FASEB J2021
33887487Feature Selection Methods for Protein Biomarker Discovery from Proteomics or Multiomics Data.Mol Cell Proteomics2021
33450205Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.Cell2021
34036290A community effort to identify and correct mislabeled samples in proteogenomic studies.Patterns (N Y)2021
33767418Proteogenomics drives therapeutic hypothesis generation for precision oncology.Br J Cancer2021
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
34737085Deep-Learning-Derived Evaluation Metrics Enable Effective Benchmarking of Computational Tools for Phosphopeptide Identification.Mol Cell Proteomics2021
34622160caAtlas: An immunopeptidome atlas of human cancer.iScience2021
  • 1 - 50 of 288

Recommended Authors

Anthony J Cesnik
University of Wisconsin-Madison
Career Start Year 2015
Number of shared co-authors 10
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 23
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Fan Zhang
College of Life Sciences, ShanDong Normal University
Career Start Year 2009
Number of shared co-authors 0
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 21
Ludwig Geistlinger
Center for Computational Biomedicine, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 2
Yuanfang Guan
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 9
J??ri Reimand
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 14
Andrey Alexeyenko
Karolinska Institutet
Career Start Year 2006
Number of shared co-authors 2
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 1
Alex Ignatchenko
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2005
Number of shared co-authors 1
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Career Start Year 2005
Number of shared co-authors 11
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 2
Andrey Sivachenko
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 1
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Career Start Year 2003
Number of shared co-authors 0
Ted Laderas
Oregon Health & Science University
Career Start Year 2003
Number of shared co-authors 2
F??tima Al-Shahrour
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 4
Max Kotlyar
Schroeder Arthritis Institute
Career Start Year 2002
Number of shared co-authors 1
Ruth Isserlin
University of Toronto
Career Start Year 2002
Number of shared co-authors 1
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 0
Gary D Bader
University of Toronto
Career Start Year 2000
Number of shared co-authors 13
Victor Segura
Center for Applied Medical Research (CIMA)
Career Start Year 2000
Number of shared co-authors 6
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 4
Youping Deng
John A. Burns School of Medicine, University of Hawaii at Manoa
Career Start Year 1999
Number of shared co-authors 2
Lars Juhl Jensen
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 1998
Number of shared co-authors 2
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 1
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 3
Jill P Mesirov
University of California San Diego
Career Start Year 1992
Number of shared co-authors 10
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 12

Collaborators

Bo Wen
Co-authored papers 22
Zhiao Shi
Co-authored papers 21
Jing Wang
Co-authored papers 19
Xiaojing Wang
Co-authored papers 19
Daniel C Liebler
Co-authored papers 18
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 16
Matthew J Ellis
Co-authored papers 14
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 13
Robert J Coffey
Co-authored papers 12
Pei Wang
Co-authored papers 12
Suhas Vasaikar
Co-authored papers 12
Yongchao Dou
Co-authored papers 11
Jonathan T Lei
Co-authored papers 10
Ana I Robles
Co-authored papers 10
Christopher R Kinsinger
Co-authored papers 10
David L Tabb
Co-authored papers 10
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
Mehdi Mesri
Co-authored papers 9
Kai Li
Co-authored papers 9
Robbert J C Slebos
Co-authored papers 9
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 9
Jason E McDermott
Pacific Northwest National Laboratory
Co-authored papers 8
Xi Chen
Co-authored papers 8
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 8
Yuxing Liao
Co-authored papers 8
Alissa M Weaver
Co-authored papers 8
Zhen Zhang
Co-authored papers 8
Yize Li
Co-authored papers 7
Meenakshi Anurag
Co-authored papers 7
Karin D Rodland
Oregon Health and Science University
Co-authored papers 7
Release 1.2